Intra-arterial thrombolysis via urokinase following reperfusion by endovascular thrombectomy for stroke does not affect survival without disability.
The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Individuals with high PLMs had significantly higher Fazekas and ARWMC total scores than those with a lower PLM index.
The U.S. Food and Drug Administration (FDA) has released several important updates addressing new medication approvals and ...